Coming soon: stem cell showdown

For indispensable reporting on the coronavirus crisis, the election, and more, subscribe to the Mother Jones Daily newsletter.


From the Washington Post:

Senate leaders from both parties agreed yesterday to schedule a vote on a package of bills that would loosen President Bush’s five-year-old restrictions on human embryonic stem cell research.

With head counts suggesting there are enough votes to pass the legislation and with Bush having promised he would veto it, yesterday’s action sets the stage for what could be the first full-blown showdown between the chamber and the president.

Bring it!

The package would allow federal funding of research on embryos slated for destruction at fertility clinics–embryos rich in the useful kind of stem cell. (Bush yesterday called them “society’s vulnerable members.” How’s that for a frame?)
As Mother Jones reports this month, there are lots and lots and lots of those embryos.

And so, far from going away, the accumulation of human embryos is likely to grow, and grow, and grow. And in growing, the embryo overstock is likely to change—or at least complicate—the way we collectively think about human life at its earliest stages, and morally what is the right thing to do with it. At some point, embryos may alter or even explode the reproductive landscape: It is ivf embryos, after all, that are at the center of the nation’s stem cell debate, which itself has prompted a new national conversation about life and reproductive liberty, creating new alliances as well as schisms. In 2001, as one of his first major domestic policy decisions, George W. Bush banned federal funding for labs developing new stem cell lines using leftover ivf embryos; then in May 2005, the U.S. House of Representatives passed a bill approving funding for stem cell research using these same embryos, setting the stage for an eventual conservative showdown. In the course of this debate, embryos have emerged as another tool for truly hardline conservatives looking for new ways to beat back abortion rights. Like “fetal rights” laws that seemingly protect unborn children from acts of homicide, “embryo rights” are being waved about as a weapon in the assault on abortion rights, as anti-abortion lawmakers talk about seizing control over frozen embryo stores; limiting the creation of new embryos; or both.

But the impact of the embryo is also taking place on a more subtle and personal level. The glut’s very existence illuminates how the newest reproductive technologies are complicating questions about life; issues that many people thought they had resolved are being revived and reconsidered, in a different emotional context.

Read the full article, by Liza Mundy, here.

DOES IT FEEL LIKE POLITICS IS AT A BREAKING POINT?

Headshot of Editor in Chief of Mother Jones, Clara Jeffery

It sure feels that way to me, and here at Mother Jones, we’ve been thinking a lot about what journalism needs to do differently, and how we can have the biggest impact.

We kept coming back to one word: corruption. Democracy and the rule of law being undermined by those with wealth and power for their own gain. So we're launching an ambitious Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption, and asking the MoJo community to help crowdfund it.

We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We want to dig into the forces and decisions that have allowed massive conflicts of interest, influence peddling, and win-at-all-costs politics to flourish.

It's unlike anything we've done, and we have seed funding to get started, but we're looking to raise $500,000 from readers by July when we'll be making key budgeting decisions—and the more resources we have by then, the deeper we can dig. If our plan sounds good to you, please help kickstart it with a tax-deductible donation today.

Thanks for reading—whether or not you can pitch in today, or ever, I'm glad you're with us.

Signed by Clara Jeffery

Clara Jeffery, Editor-in-Chief

payment methods

We Recommend

Latest